Ah. Shankar et al., The influence of zinc supplementation on morbidity due to Plasmodium falciparum: A randomized trial in preschool children in Papua New Guinea, AM J TROP M, 62(6), 2000, pp. 663-669
Citations number
31
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Zinc is crucial for normal immune function and can reduce morbidity from mu
ltiple infectious diseases. To determine the influence of zinc on malaria m
orbidity we conducted a randomized placebo-controlled trial of daily zinc s
upplementation in children residing in a malaria endemic region of Papua Ne
w Guinea. A total of 274 preschool children aged 6 to 60 months were given
10 mg elemental zinc (n = 136) or placebo (n = 138) for 6 days a week for 4
6 weeks. Slide-confirmed malaria episodes were detected by surveillance of
cases self-reporting to a local health center. Cross-sectional surveys were
conducted at the beginning, middle, and end of the study to assess infecti
on rates, parasite density, spleen enlargement, and hemoglobin levels. Zinc
supplementation resulted in a 38% (95% CI 3-60, P = 0.037) reduction in Pl
asmodium falciparum health center-based episodes, defined as parasitemia gr
eater than or equal to 9200 parasites/mul with axial temperature greater th
an or equal to 37.5 degreesC or reported fever. Episodes accompanied by any
parasitemia were also reduced by 38% (95% CI 5-60, P = 0.028), and episode
s with parasitemia greater than or equal to 100,000/mul were reduced by 69%
(95% CI 25-87, P = 0.009). There was no evidence of the effects of zinc on
Plasmodium vivax morbidity or on health center attendance for causes other
than P. falciparum. Zinc had no consistent effect on cross-sectional malar
iometric indices. Although P. falciparum prevalence tended to be lower at t
he end of the study in children given the placebo, such changes were absent
at the mid-study survey. These results suggest that improved dietary zinc
intake may reduce morbidity due to P. falciparum.